- Home :
Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context
Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising
17 January 2017 M36 meeting in Brussels
To allow presentation of project results and direct interaction with our Project Officer, TumAdoR consortium will organized its M36 biannual meeting in Brussels.
17 January 2017 M30 meeting in San Antonio
We had a gren ligh to meet in Texas. The meeting wll be organized by THSCSA on 9 and 1àth of March 2016.